omniture
logo
Search
EXOCOBIO INC.
Media Room

Latest News

rss

ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)

-  The first plant stem cell-derived exosome patent in the US -  The 5th patent allowance following...

2023-05-19 16:34 3858
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)

ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA

* ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. * Cellos...

2023-03-02 14:09 3967
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA

ExoCoBio's First Global Regenerative Aesthetic Exosome Summit

* World First Regenerative Aesthetic Exosome Summit (RAES 2022) * Participation of Global Exosom...

2022-08-16 15:00 6338
ExoCoBio's First Global Regenerative Aesthetic Exosome Summit

ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome

* To lay a technological foundation for developing exosome-based medicines and cosmetic products ...

2022-05-09 07:00 3437

ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility

* $20 million investment for a new Mfg & R&D facility * Strategic platform for partnering & CDMO...

2021-08-25 19:44 1810
ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility

ExoCoBio Inc. raises $9.3M in Pre-IPO Financing

* Its exosome-based regenerative aesthetics business is fast growing. * The IPO process will be ...

2020-08-25 22:00 3066
ExoCoBio Inc. raises $9.3M in Pre-IPO Financing